Surrozen, Inc. - Common Stock (SRZN)

Surrozen (NASDAQ:SRZN) Chief Executive Officer Craig Parker outlined the company’s rationale for developing Wnt-targeting retinal disease therapies during H.C. Wainwright’s 6th Annual Ophthalmology Investor Conference, emphasizing the company’s focus on Frizzled-4 signaling, anti-VEGF activity and,

SRZN stock results show that Surrozen beat analyst estimates for earnings per share the first quarter of 2024.

SRZN stock results show that Surrozen beat analyst estimates for earnings per share the second quarter of 2023.

SRZN stock results show that Surrozen missed analyst estimates for earnings per share the second quarter of 2024.

Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results.

Surrozen engages in a private placement, aiming to raise approximately $192.5 million in gross proceeds. Updates on SZN-043 Phase 1a trial reveal promising safety, tolerability, and effects on liver function.

SRZN stock results show that Surrozen missed analyst estimates for earnings per share the first quarter of 2023.

SRZN stock results show that Surrozen missed analyst estimates for earnings per share the third quarter of 2023.

Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.

Companies Reporting Before The Bell • Boyd Gaming (NYSE:BYD) is estimated to report quarterly earnings at $1.09 per share on revenue of $848.27 million.

Gainers

We're starting off Friday with an overview of the biggest pre-market stock movers traders will want to keep an eye on today!

Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday.